A major discovery in cancer study is emerging with the use of mini-antibodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently disabled in many forms of malignancies, causing https://yesbookmarks.com/story22032827/nanobodies-revive-p53-the-new-pathway-for-cancer-management